首页> 外文学位 >Signalling pathways involved in cell transformation and conversion of phenotype.
【24h】

Signalling pathways involved in cell transformation and conversion of phenotype.

机译:涉及细胞转化和表型转化的信号通路。

获取原文
获取原文并翻译 | 示例

摘要

Polypeptides encoded by several oncogenes or tumor suppressor genes are involved in signalling pathways/networks mediating the transformation and phenotype conversion of cells. p185neu, a member of the ErbB family of receptor tyrosine kinases (RTKs), contributes to transformation by its capability to dimerize with itself and other receptors as well as via its kinase activity. A single residue, tyrosine882, may be important because of its location in the kinase domain. Substitution of tyrosine882 with phenylalanine, which diminished the enzymatic tyrosine kinase activity of p185neu, significantly decreased the transforming potential of activated oncogenic p185 neu.; To understand the growth inhibitory activity of BRCA1, a breast/ovarian cancer suppressor gene, we analyzed the relationship of the products of neu and BRCA1, both known to be important in the transformation of breast cells. BRCA1 was identified as a tyrosine phosphorylated protein localized primarily in the nucleus of several breast cancer cell lines. The tyrosine phosphorylation pattern of BRCA1 was also related to events in the cell cycle. In transformed murine and human cells, phosphorylated-tyrosine levels of BRCA1 were inversely correlated with the activity of the erbB family receptor-tyrosine-kinases as well as with the transformed growth features of these cells. More directly, BRCA1 inhibited transformation mediated by oncogenic neu in focus formation assays. Further analysis revealed that c-myc, a proto-oncogene, was unexpectedly required for neu-mediated transformation. Interestingly, c-Myc polypeptides can directly associate with BRCA1. BRCA1 represses Myc-mediated transcription and reverses the phenotype of embryonic fibroblasts transformed by the activation of Myc and Ras.; Taken together, our data suggest that neu, BRCA1, and c-myc are three critical elements involved in a linked signalling pathway involved in cell transformation and phenotype conversion. Acting as a growth repressor in this pathway, BRCA1 can interact and block functional c-Myc which is required for neu mediated transformation. BRCA1 also associates with VCP (Valise containing protein), an ATP binding protein that may transport ATP molecules for recognition of mis-matched DNA. Combined with other observations that BRCA1 can interact with some proteins involved in DNA repair, our studies also suggest that BRCA1 may connect this putative signalling pathway to DNA damage repair.
机译:由几种致癌基因或抑癌基因编码的多肽参与介导细胞转化和表型转化的信号通路/网络。 p185 neu 是受体酪氨酸激酶(RTKs)的ErbB家族的成员,通过其与自身和其他受体二聚的能力以及通过其激酶而有助于转化活动。单个残基酪氨酸 882 可能很重要,因为它位于激酶结构域中。用苯丙氨酸取代酪氨酸 882 会降低p185 neu 的酶酪氨酸激酶活性,从而显着降低活化的致癌p185 neu 。为了了解乳腺癌/卵巢癌抑制基因BRCA1的生长抑制活性,我们分析了neu和BRCA1的产物之间的关系,两者在乳腺癌细胞的转化中起着重要的作用。 BRCA1被确定为酪氨酸磷酸化蛋白,主要位于几种乳腺癌细胞系的细胞核中。 BRCA1的酪氨酸磷酸化模式也与细胞周期中的事件有关。在转化的鼠类和人类细胞中,BRCA1的磷酸化酪氨酸水平与erbB家族受体酪氨酸激酶的活性以及这些细胞的转化生长特征成反比。更直接地,在焦点形成试验中,BRCA1抑制了由致癌性神经元介导的转化。进一步的分析表明,原癌基因c-myc意外地需要neu介导的转化。有趣的是,c-Myc多肽可以直接与BRCA1缔合。 BRCA1抑制Myc介导的转录,并逆转由Myc和Ras激活转化的胚胎成纤维细胞的表型。综上所述,我们的数据表明, neu ,BRCA1和c-myc是参与细胞转化和表型转化的连锁信号通路的三个关键要素。在此途径中,BRCA1充当生长抑制因子,可以相互作用并阻断 neu 介导的转化所需的功能性c-Myc。 BRCA1还与VCP(含Valise的蛋白质)相关联,VCP是一种ATP结合蛋白,可以转运ATP分子以识别错配的DNA。结合BRCA1可以与DNA修复中涉及的某些蛋白质相互作用的其他观察结果,我们的研究还表明BRCA1可能将此推定的信号通路与DNA损伤修复相关联。

著录项

  • 作者

    Zhang, Hongtao.;

  • 作者单位

    University of Pennsylvania.;

  • 授予单位 University of Pennsylvania.;
  • 学科 Biology Cell.; Biology Molecular.
  • 学位 Ph.D.
  • 年度 1999
  • 页码 144 p.
  • 总页数 144
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 细胞生物学;分子遗传学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号